Targeted Treatment in Chronic Inflammatory Arthritis
A special issue of Journal of Clinical Medicine (ISSN 2077-0383). This special issue belongs to the section "Immunology".
Deadline for manuscript submissions: 28 February 2025 | Viewed by 45
Special Issue Editors
Interests: systemic sclerosis; rheumatoid arthritis; psoriatic arthritis
Special Issues, Collections and Topics in MDPI journals
Interests: rheumatology; rheumatoid arthritis; psoriatic arthritis; ostarthritis
Special Issues, Collections and Topics in MDPI journals
2. Division of Clinical Immunology, Fondazione Policlinico Universitario A. Gemelli IRCCS, Università Cattolica del Sacro Cuore—Rome, 00168 Rome, Italy
Interests: clinical rheumatology; inflammation; rheumatic diseases; autoantibodies; knee osteoarthritis; rheumatology; autoimmunity
Special Issues, Collections and Topics in MDPI journals
Special Issue Information
Dear Colleagues,
This Special Issue of the Journal of Clinical Medicine (JCM) focuses on “Targeted Treatment in Chronic Inflammatory Arthritis” and aims to provide a comprehensive overview of the latest advancements in targeted therapies within the scope of clinical medicine. The primary objective of this Special Issue is to present original research articles, systematic reviews, and meta-analyses that explore the efficacy, safety, and clinical outcomes of targeted treatment approaches in chronic inflammatory arthritis.
Specific areas of interest for this Special Issue include, but are not limited to, the following:
- Evaluation of the effectiveness and long-term outcomes of targeted therapies in different types of chronic inflammatory arthritis.
- Assessment of the impact of targeted therapies on disease progression, remission rates, quality of life, and comorbidities in patients with chronic inflammatory arthritis.
- Comparative studies analyzing the efficacy and safety profiles of different targeted treatment modalities.
We invite researchers, clinicians, and scholars in the field of clinical medicine to contribute their valuable insights and findings to this Special Issue. Together, we can advance our understanding of targeted treatment options and improve the management of chronic inflammatory arthritis.
Dr. Cinzia Rotondo
Dr. Simone Parisi
Dr. Simone Perniola
Guest Editors
Manuscript Submission Information
Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.
Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Journal of Clinical Medicine is an international peer-reviewed open access semimonthly journal published by MDPI.
Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 2600 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.
Keywords
- rheumatoid arthritis
- psoriatic arthritis
- ankylosing spondylitis
- spondyloarthritis
- disease-modifying antirheumatic drugs (DMARDs)
- personalized medicine
- immunomodulatory therapies
- patient outcomes
- combination therapies
